Rheumatoid Arthritis Clinical Trials in Phoenix

Showing 1001-1020 of 3,170 trials

Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMD

NCT05210803

This is a prospective, observational study designed to evaluate the long-term safety and efficacy of RGX-314. Eligible participants are those who were previously enrolled in a clinical study of nAMD in which they received suprachoroidal space (SCS) administration of RGX-314. Enrollment of each participant in the current study should occur after the participant has completed either the end of study or early discontinuation visit in the previous (parent) clinical study. Participants will be followed for up to 5 years after RGX-314 administration (inclusive of the parent study). As such, the total study duration for each participant may vary depending on when they enroll in the current study following RGX-314 administration in the parent study.

Neovascular Age-Related Macular Degeneration (nAMD)Gene TherapyAMD+3 more

AbbVie115 participantsStarted Dec 2021

Phoenix, Arizona, United States • Bakersfield, California, United States • Beverly Hills, California, United States +13 more locations

COMPLETEDPhase 2< 1 mile

A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TRAILBLAZER-EXT)

NCT04640077

The main goals of this study are to further determine whether the study drug donanemab is safe and effective in participants with Alzheimer's disease and to validate neuropsychological assessments administered over videoconferencing

Alzheimer DiseaseDementiaBrain Diseases+2 more

Eli Lilly and Company95 participantsStarted Nov 2020

Phoenix, Arizona, United States • Irvine, California, United States • Bradenton, Florida, United States +24 more locations

Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMD

A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TRAILBLAZER-EXT)

Rheumatoid Arthritis Trials in Other Cities

Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Study of a Respiratory Syncytial Virus Candidate Encapsulated in a Lipid Nanoparticle Based Formulation in Adults Aged 18 to 50 Years and 60 Years and Older

Prospective Observational Cohort Study of Fetal Atrial Flutter & Supraventricular Tachycardia

A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

ProVIDE II Bridging Study

Safety and Efficacy Study of Cefepime/VNRX-5133 in Patients With Complicated Urinary Tract Infections

Multi-Center Adolescent Clavicle Fracture Trial: Operative vs. Non-Operative Treatment

REpeated ASSEssment of SurvivorS in Intracerebral Hemorrhage Study

RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD

Study of the Relay Pro® Thoracic Stent-Graft in Subjects With Traumatic Injury of the Descending Thoracic Aorta

Comprehensive HHT Outcomes Registry of the United States (CHORUS)

Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study

Visual Performance of Clareon PanOptix vs. a Comparable Multifocal Intraocular Lens

A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1)

Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001

Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial

Cross-linking for Corneal Ulcers Treatment Trial

Other Conditions in Phoenix